A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rucaparib Impurity 17 | CAS 2913-97-5 - Request Quote

Picture of Rucaparib Impurity 17

Rucaparib Impurity 17

SZ CAT No:SZ-R055021
CAS No
2913-97-5
Mol.F.
C10H7NO3
Mol.Wt.
189.2
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Rucaparib Impurity 17 is chemically 2-(1,3-Dioxoisoindolin-2-yl)acetaldehyde. Rucaparib Impurity 17 is supplied with detailed characterization data compliant with regulatory guideline. Rucaparib Impurity 17 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Rucaparib.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2913-97-5

Purchase 2913-97-5

Order 2913-97-5

Enquire 2913-97-5

price of 2913-97-5

2913-97-5 Supplier

2913-97-5 Manufacturer

2913-97-5 Exporter

buy high quality Rucaparib Impurity 17

Purchase Rucaparib Impurity 17

Rucaparib Impurity 17 suppliers

Rucaparib Impurity 17 manufacturers

Rucaparib Impurity 17 price

Order Rucaparib Impurity 17

Enquire Rucaparib Impurity 17

Rucaparib Impurity 17 cost

Rucaparib Impurity 17 Supplier

Rucaparib Impurity 17 Distributor

Rucaparib Impurity 17 for Method Validation

Rucaparib Reference Standard

Rucaparib Impurity 17 for ANDA Filing

Rucaparib Impurity 17 for Forced Degradation Studies

Rucaparib Impurity 17 Identification Standards

Rucaparib Impurity 17 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,